Protein Kinase C Inhibition in the Treatment of Mania
Authors:
- Ayşegül YildizAYAyşegül Yildiz
- Sebnem GuleryuzSGSebnem Guleryuz
- Donna Pauler AnkerstDADonna Pauler Ankerst
- Dost ÖngürDÖDost Öngür
- Perry F. RenshawPRPerry F. Renshaw
- 1 March 2008
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 65 (3) , 255-263
Abstract
Research from JAMA Psychiatry — Protein Kinase C Inhibition in the Treatment of Mania — A Double-blind, Placebo-Controlled Trial of TamoxifenKeywords
This publication has 43 references indexed in Scilit:
- Cellular Plasticity Cascades: Targets for the Development of Novel Therapeutics for Bipolar DisorderBiological Psychiatry, 2006
- Cellular Plasticity Cascades: Genes-To-Behavior Pathways in Animal Models of Bipolar DisorderBiological Psychiatry, 2006
- Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patientsJournal of Psychiatric Research, 2005
- Increased association of brain protein kinase C with the receptor for activated C kinase-1 (RACK1) in bipolar affective disorderBiological Psychiatry, 2001
- Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illnessBiological Psychiatry, 1999
- Increased membrane-associated protein kinase C activity and translocation in blood platelets from bipolar affective disorder patientsJournal of Psychiatric Research, 1999
- Enhanced protein kinase C activity and translocation in bipolar affective disorder brainsBiological Psychiatry, 1996
- Chronic Sodium Valproate Selectively Decreases Protein Kinase C α and ε In VitroJournal of Neurochemistry, 1994
- Altered platelet protein kinase C activity in bipolar affective disorder, manic episodeBiological Psychiatry, 1993
- Lithium inhibition of protein kinase C activation-induced serotonin releasePsychopharmacology, 1989